Home068270 • KRX
add
Celltrion Inc
Nakaraang pagsara
₩197,200.00
Sakop ng araw
₩200,000.00 - ₩207,000.00
Sakop ng taon
₩144,615.31 - ₩251,000.00
Market cap
47.60T KRW
Average na Volume
560.82K
P/E ratio
44.21
Dividend yield
0.36%
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.33T | 25.06% |
Gastos sa pagpapatakbo | 383.06B | 10.26% |
Net na kita | 528.43B | 123.30% |
Net profit margin | 39.73 | 78.56% |
Kita sa bawat share | 2.40K | 117.62% |
EBITDA | 537.36B | 95.28% |
Aktuwal na % ng binabayarang buwis | -0.01% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.24T | 8.40% |
Kabuuang asset | 22.33T | 6.08% |
Kabuuang sagutin | 4.98T | 43.37% |
Kabuuang equity | 17.35T | — |
Natitirang share | 218.61M | — |
Presyo para makapag-book | 2.51 | — |
Return on assets | 5.42% | — |
Return on capital | 5.77% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 528.43B | 123.30% |
Cash mula sa mga operasyon | 139.88B | -54.28% |
Cash mula sa pag-invest | -629.48B | -520.17% |
Cash mula sa financing | 754.75B | 429.67% |
Net change in cash | 309.21B | 1,200.88% |
Malayang cash flow | -160.53B | -362.61% |
Tungkol
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
1,074
